#METABOLOMICS WORKBENCH usauamber_20231109_102504 DATATRACK_ID:4451 STUDY_ID:ST002979 ANALYSIS_ID:AN004896
VERSION                          	1
CREATED_ON                       	11-21-2023
#PROJECT
PR:PROJECT_TITLE                 	Integrated multi-omics reveals mTOR-LPL-driven dysregulated lipid metabolism
PR:PROJECT_TITLE                 	induces neuronal hyperexcitability in human microglia of tuberous sclerosis
PR:PROJECT_TITLE                 	complex
PR:PROJECT_SUMMARY               	Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder
PR:PROJECT_SUMMARY               	caused by mutations in either TSC1 or TSC2. There's evidence suggests a
PR:PROJECT_SUMMARY               	connection between microglia activation and epilepsy as well as cognitive
PR:PROJECT_SUMMARY               	impairment in TSC patients. However, how the causal variants of TSC1/2 genes
PR:PROJECT_SUMMARY               	identified in TSC patients affect human microglia and how they contribute to the
PR:PROJECT_SUMMARY               	neurological manifestations. This project is focus on this problem using human
PR:PROJECT_SUMMARY               	microglia generated from induced pluripotent stem cells (iPSCs) derived from a
PR:PROJECT_SUMMARY               	TSC patient.
PR:INSTITUTE                     	St Jude Children's Research Hospital
PR:LAST_NAME                     	Xie
PR:FIRST_NAME                    	Boer
PR:ADDRESS                       	262 Danny Thomas Place, Memphis, TN, 38105, USA
PR:EMAIL                         	xbr429@gmail.com
PR:PHONE                         	(901) 595-7499
PR:DOI                           	http://dx.doi.org/10.21228/M8XT6T
#STUDY
ST:STUDY_TITLE                   	Untargeted lipidomics profiling of TSC microglia
ST:STUDY_SUMMARY                 	In this study, human microglia from induced pluripotent stem cells (iPSCs)
ST:STUDY_SUMMARY                 	derived from a TSC patient cohort were generated . With a comprehensively
ST:STUDY_SUMMARY                 	molecular and cellular characterization on TSC microglia, including
ST:STUDY_SUMMARY                 	transcriptomics, proteomics/phosphopreteomics, and lipidomics, patient-carrying
ST:STUDY_SUMMARY                 	TSC2 mutations lead to aberrant lipid metabolism were found, in particular,
ST:STUDY_SUMMARY                 	upregulated glycerophosphocholines and fatty acyls in TSC microglia, resulting
ST:STUDY_SUMMARY                 	in increased phagocytosis and inflammation. Strikingly, the dysregulated lipid
ST:STUDY_SUMMARY                 	metabolism in TSC microglia is driven by hyper-activation of mTOR-LPL pathway.
ST:STUDY_SUMMARY                 	Furthermore, cellular and electrophysiological assessments of neuron/microglia
ST:STUDY_SUMMARY                 	co-cultures revealed that TSC microglia directly affect neuronal development and
ST:STUDY_SUMMARY                 	excitability as well as neuronal network activity, which could be largely
ST:STUDY_SUMMARY                 	ameliorated by mTOR/LPL inhibition
ST:INSTITUTE                     	St Jude Children's Research Hospital
ST:LAST_NAME                     	Xie
ST:FIRST_NAME                    	Boer
ST:ADDRESS                       	262 Danny Thomas Place, Memphis, TN, 38105, USA
ST:EMAIL                         	xbr429@gmail.com
ST:PHONE                         	(901) 595-7499
ST:SUBMIT_DATE                   	2023-11-09
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	TSC10-1	Genotype:TSC mutation	RAW_FILE_NAME=13.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC10-2	Genotype:TSC mutation	RAW_FILE_NAME=14.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC10-3	Genotype:TSC mutation	RAW_FILE_NAME=15.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC10-Homo-1	Genotype:TSC mutation	RAW_FILE_NAME=16.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC10-Homo-2	Genotype:TSC mutation	RAW_FILE_NAME=17.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC10-Homo-3	Genotype:TSC mutation	RAW_FILE_NAME=18.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC7-1	Genotype:TSC mutation	RAW_FILE_NAME=10.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC7-2	Genotype:TSC mutation	RAW_FILE_NAME=11.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC7-3	Genotype:TSC mutation	RAW_FILE_NAME=12.raw
SUBJECT_SAMPLE_FACTORS           	-	TSC7-4	Genotype:TSC mutation	RAW_FILE_NAME=26.raw
SUBJECT_SAMPLE_FACTORS           	-	12C1-1	Genotype:wildtype	RAW_FILE_NAME=19.raw
SUBJECT_SAMPLE_FACTORS           	-	12C1-2	Genotype:wildtype	RAW_FILE_NAME=20.raw
SUBJECT_SAMPLE_FACTORS           	-	12C1-3	Genotype:wildtype	RAW_FILE_NAME=21.raw
SUBJECT_SAMPLE_FACTORS           	-	12C1-4	Genotype:wildtype	RAW_FILE_NAME=22.raw
SUBJECT_SAMPLE_FACTORS           	-	426-1	Genotype:wildtype	RAW_FILE_NAME=04.raw
SUBJECT_SAMPLE_FACTORS           	-	426-2	Genotype:wildtype	RAW_FILE_NAME=05.raw
SUBJECT_SAMPLE_FACTORS           	-	426-3	Genotype:wildtype	RAW_FILE_NAME=06.raw
SUBJECT_SAMPLE_FACTORS           	-	426-4	Genotype:wildtype	RAW_FILE_NAME=24.raw
SUBJECT_SAMPLE_FACTORS           	-	C1-2-1	Genotype:wildtype	RAW_FILE_NAME=01.raw
SUBJECT_SAMPLE_FACTORS           	-	C1-2-2	Genotype:wildtype	RAW_FILE_NAME=02.raw
SUBJECT_SAMPLE_FACTORS           	-	C1-2-3	Genotype:wildtype	RAW_FILE_NAME=03.raw
SUBJECT_SAMPLE_FACTORS           	-	C1-2-4	Genotype:wildtype	RAW_FILE_NAME=23.raw
SUBJECT_SAMPLE_FACTORS           	-	PGP1-1	Genotype:wildtype	RAW_FILE_NAME=07.raw
SUBJECT_SAMPLE_FACTORS           	-	PGP1-2	Genotype:wildtype	RAW_FILE_NAME=08.raw
SUBJECT_SAMPLE_FACTORS           	-	PGP1-3	Genotype:wildtype	RAW_FILE_NAME=09.raw
SUBJECT_SAMPLE_FACTORS           	-	PGP1-4	Genotype:wildtype	RAW_FILE_NAME=25.raw
#COLLECTION
CO:COLLECTION_SUMMARY            	Cell line and sample collection were done at Emory University
CO:SAMPLE_TYPE                   	Neurons
#TREATMENT
TR:TREATMENT_SUMMARY             	No treatment applied.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Lipids were extracted from cell by cold isopropanol (10:1 v/v, solvent to
SP:SAMPLEPREP_SUMMARY            	sample). Extracted lipids were dried under nitrogen gas, resuspended in 65%
SP:SAMPLEPREP_SUMMARY            	acetonitrile, 30% isopropanol and 5% water.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_COMMENTS       	https://www.sigmaaldrich.com/US/en/product/supelco/54271u
CH:INSTRUMENT_NAME               	Waters NanoAcquity
CH:COLUMN_NAME                   	Supelco Ascentis Express C18 (15 cm X 300 µm, 2.7µm)
CH:COLUMN_TEMPERATURE            	RT
CH:FLOW_GRADIENT                 	10-75%B in 34min
CH:FLOW_RATE                     	-
CH:SOLVENT_A                     	60% water/40% acetonitrile; 10 mM ammonium formate; 0.1% formic acid
CH:SOLVENT_B                     	90% isopropanol/10% acetonitrile; 10 mM ammonium formate; 0.1% formic acid
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive HF hybrid Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	MS1:120k resolution, 100-1200 m/z, 3e6 AGC, 50 ms maximal ion time MS2:top 20,
MS:MS_COMMENTS                   	30k resolution, 2e5 AGC, 45 ms maximal ion time, stepped HCD NCE at 30, 75, 150
MS:MS_COMMENTS                   	In-house JUMPm software and Shiny were used for data processing, feature
MS:MS_COMMENTS                   	assignment and statistic analysis
MS:ION_MODE                      	NEGATIVE
MS:MS_RESULTS_FILE               	ST002979_AN004896_Results.txt	UNITS:Intensity	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END